EZH2 and hepatocellular carcinoma: Both SPRY4-IT1 and LINC00978 can recruit EZH2 to the promoter of E-cadherin, inhibiting expression of E-cadherin and facilitating the invasion and metastasis of HCC cells [34, 44].